News Releases Year: - Any -20192018201720162015201420132012 Items per page 102550 07/31/19 Summary ToggleClearside Biomedical Announces Multiple Oral Presentations Delivered at the American Society of Retinal Specialists (ASRS) Annual Meeting PDF Version 07/18/19 Summary ToggleClearside Biomedical Announces Multiple Oral Presentations to be Given at the American Society of Retinal Specialists (ASRS) Annual Meeting PDF Version 07/09/19 Summary ToggleClearside Biomedical Announces License Agreement with Aura Biosciences for Suprachoroidal Space Microinjector™ Designed to Optimize Ocular Oncology Drug Delivery PDF Version 06/11/19 Summary ToggleClearside Biomedical to Present at the JMP Securities Life Sciences Conference PDF Version 05/15/19 Summary ToggleClearside Biomedical to Present at the UBS Global Healthcare Conference PDF Version 05/08/19 Summary ToggleClearside Biomedical Announces First Quarter 2019 Financial Results and Provides Corporate Update PDF Version 05/01/19 Summary ToggleClearside Biomedical’s Suprachoroidal Space Injection Platform Featured at Multiple Ophthalmology and Gene Therapy Medical Meetings PDF Version 04/25/19 Summary ToggleClearside Biomedical to Report First Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, May 8, 2019 PDF Version 04/18/19 Summary ToggleClearside Biomedical Announces Multiple Presentations on its Suprachoroidal Space® Injection Platform at Upcoming Medical Meetings PDF Version 04/08/19 Summary ToggleClearside Biomedical Appoints Dr. George Lasezkay as Interim CEO PDF Version Pagination First page First Previous page Page 1 Current page 2 Page 3 Page 4 Next page Last page Last
